WeTrials
Recruiting

JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial

What is this study?

This study is comparing two different treatments for a common type of early-stage lung cancer called non-small cell lung cancer. Researchers want to find out if high-energy radiation therapy helps patients live longer compared to surgery that removes a smaller part of the lung (sublobar resection), in people at higher risk from standard surgery.

Who can participate?

This study is actively recruiting adults aged 18 and older who have early-stage lung cancer and are well enough to perform daily activities. You may be able to join if your tumor meets specific size requirements and is confirmed by recent scans and tissue samples. The study is for people whose surgeon says they can have surgery but that a standard lobectomy would carry higher risk for them (for example, because of reduced lung function), with a tumor 4 cm or smaller in the outer part of the lung.

What will happen?

Each participant's group is chosen at random, by chance, not by you or your doctor. One group will receive lung surgery to remove the tissue, while the other group will receive specialized radiation therapy using high-energy X-rays.

Where and when?

This study is currently recruiting participants at 12 sites in 3 countries: the United States, Canada and Australia.

Key Points
  • 1The study compares lung surgery with high-energy radiation therapy for early-stage lung cancer.
  • 2Treatment groups are assigned completely by chance.
  • 3The trial is currently open and looking for new participants at 12 study locations in 3 countries: the United States, Canada and Australia.

Related video

Early Lung Cancer: Is Radiation as Good as Surgery? What 12,500 Patients Showed

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Non-Small Cell Lung Cancer

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.